{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:24:15Z","timestamp":1787109855008,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":6408,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.anpedi.2008.10.010","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T04:03:05Z","timestamp":1253764985000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizaci\u00f3n del tratamiento con azatioprina: determinaci\u00f3n de la actividad de tiopurina metiltransferasa y las concentraciones de metabolitos tiopur\u00ednicos"],"prefix":"10.1016","volume":"70","author":[{"given":"M.","family":"\u00c1lvarez Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Infante Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tormo Carnic\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Segarra Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Redecillas Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2008.10.010_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anpedi.2008.10.010_bib2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/j.1572-0241.2006.00843.x","article-title":"Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib3","first-page":"450","article-title":"6-mercaptopurine metabolite levels in children with inflammatory bowel disease","volume":"33","author":"Gupta","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2008.10.010_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.48.5.642","article-title":"Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease","volume":"48","author":"Cuffari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.anpedi.2008.10.010_bib5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","article-title":"Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis","volume":"130","author":"Osterman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anpedi.2008.10.010_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.49.5.665","article-title":"Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease","volume":"49","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.anpedi.2008.10.010_bib7","first-page":"12","article-title":"Utilidad de la determinaci\u00f3n de los niveles plasm\u00e1ticos de nucle\u00f3tidos de la 6-tioguanina (6-TGN) como marcador de la eficacia de la azatioprina (AZA) y mercaptopurina (MP) en la enfermedad inflamatoria intestinal: Estudio METAZA","author":"Gisbert","year":"2007","journal-title":"GETECCU"},{"key":"10.1016\/j.anpedi.2008.10.010_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.mpg.0000228135.31793.9f","article-title":"Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center","volume":"43","author":"Banerjee","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2008.10.010_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.mpg.0000237940.50791.70","article-title":"Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway","volume":"43","author":"Colletti","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2008.10.010_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib11","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity","volume":"111","author":"Present","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anpedi.2008.10.010_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.2006.02977.x","article-title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease","volume":"24","author":"Hindorf","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2008.10.010_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.anpedi.2008.10.010_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004836-200006000-00011","article-title":"Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease","volume":"30","author":"Kader","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2036.2005.02419.x","article-title":"6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine","volume":"21","author":"Roblin","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2008.10.010_bib17","article-title":"A 6-thioguanine nucleotide threshold level of 400pmol\/8\u00d710(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity","volume":"26","author":"Roblin","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","article-title":"6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease","volume":"122","author":"Dubinsky","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anpedi.2008.10.010_bib19","first-page":"568","article-title":"Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease","volume":"29","author":"Gisbert","year":"2006","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.anpedi.2008.10.010_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0210-5705(02)70275-6","article-title":"Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease","volume":"25","author":"Gisbert","year":"2002","journal-title":"Gastroenterol Hepatol"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:27:08Z","timestamp":1787106428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403308000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1695403308000684"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.10.010","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizaci\u00f3n del tratamiento con azatioprina: determinaci\u00f3n de la actividad de tiopurina metiltransferasa y las concentraciones de metabolitos tiopur\u00ednicos","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Asociacin Espaola de Pediatra. Todos los derechos reservados. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}